Earnings Estimate | Current Qtr. (Dec 2018) | Next Qtr. (Mar 2019) | Current Year (2018) | Next Year (2019) |
---|---|---|---|---|
No. of Analysts | 0 | 0 | 0 | 0 |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | 1.7 | 1.37 | N/A | N/A |
Revenue Estimate | Current Qtr. (Dec 2018) | Next Qtr. (Mar 2019) | Current Year (2018) | Next Year (2019) |
---|---|---|---|---|
No. of Analysts | 2 | 0 | 19 | 19 |
Avg. Estimate | 30.18B | N/A | 114.58B | 124.97B |
Low Estimate | 29.84B | N/A | 110.88B | 119.29B |
High Estimate | 30.53B | N/A | 118.1B | 130.82B |
Year Ago Sales | 27.13B | N/A | 104.47B | 114.58B |
Sales Growth (year/est) | 11.30% | N/A | 9.70% | 9.10% |
Earnings History | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 |
---|---|---|---|---|
EPS Est. | 1.7 | 1.78 | 1.64 | 1.52 |
EPS Actual | 1.7 | 1.37 | 2.51 | 0.9 |
Difference | 0 | -0.41 | 0.87 | -0.62 |
Surprise % | 0.00% | -23.00% | 53.00% | -40.80% |
EPS Trend | Current Qtr. (Dec 2018) | Next Qtr. (Mar 2019) | Current Year (2018) | Next Year (2019) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 1.17 | 2.3 | 6.98 | 8.28 |
30 Days Ago | 1.17 | 2.3 | 6.98 | 8.28 |
60 Days Ago | 1.17 | 2.3 | 6.98 | 8.28 |
90 Days Ago | 1.17 | 2.3 | 6.98 | 8.28 |
EPS Revisions | Current Qtr. (Dec 2018) | Next Qtr. (Mar 2019) | Current Year (2018) | Next Year (2019) |
---|---|---|---|---|
Up Last 7 Days | N/A | N/A | N/A | N/A |
Up Last 30 Days | N/A | N/A | N/A | N/A |
Down Last 7 Days | N/A | N/A | N/A | N/A |
Down Last 30 Days | N/A | N/A | N/A | N/A |
Growth Estimates | AMBUJACEM.BO | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current Qtr. | N/A | N/A | N/A | N/A |
Next Qtr. | N/A | N/A | N/A | N/A |
Current Year | N/A | N/A | N/A | N/A |
Next Year | N/A | N/A | N/A | N/A |
Next 5 Years (per annum) | -5.30% | N/A | N/A | N/A |
Past 5 Years (per annum) | N/A | N/A | N/A | N/A |